215 related articles for article (PubMed ID: 20514787)
61. Histologic and ultrastructural analysis of melasma after fractional resurfacing.
Goldberg DJ; Berlin AL; Phelps R
Lasers Surg Med; 2008 Feb; 40(2):134-8. PubMed ID: 18306153
[TBL] [Abstract][Full Text] [Related]
62. Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device.
Tan KL; Kurniawati C; Gold MH
J Drugs Dermatol; 2008 Aug; 7(8):774-7. PubMed ID: 18720695
[TBL] [Abstract][Full Text] [Related]
63. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
Farshi S; Mansouri P; Kasraee B
J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
[TBL] [Abstract][Full Text] [Related]
64. Novel post-treatment care after ablative and fractional CO2 laser resurfacing.
Duplechain JK; Rubin MG; Kim K
J Cosmet Laser Ther; 2014 Apr; 16(2):77-82. PubMed ID: 24131071
[TBL] [Abstract][Full Text] [Related]
65. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis.
Taibjee SM; Cheung ST; Laube S; Lanigan SW
Br J Dermatol; 2005 Nov; 153(5):960-6. PubMed ID: 16225606
[TBL] [Abstract][Full Text] [Related]
66. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
67. Comparison between Intralesional Triamcinolone and Kligman's Formula in Treatment of Melasma.
Eshghi G; Khezrian L; Esna Ashari F
Acta Med Iran; 2016 Jan; 54(1):67-71. PubMed ID: 26853293
[TBL] [Abstract][Full Text] [Related]
68. Utilizing combination therapy to optimize melasma outcomes.
Rendon MI
J Drugs Dermatol; 2004; 3(5 Suppl):S27-34. PubMed ID: 15552597
[TBL] [Abstract][Full Text] [Related]
69. Improving the outcome of fractional CO2 laser resurfacing using a probiotic skin cream: Preliminary clinical evaluation.
Zoccali G; Cinque B; La Torre C; Lombardi F; Palumbo P; Romano L; Mattei A; Orsini G; Cifone MG; Giuliani M
Lasers Med Sci; 2016 Nov; 31(8):1607-1611. PubMed ID: 27412287
[TBL] [Abstract][Full Text] [Related]
70. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
[TBL] [Abstract][Full Text] [Related]
71. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
Gollnick HP; Graupe K; Zaumseil RP
Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
[TBL] [Abstract][Full Text] [Related]
72. Novel use of erbium:YAG (2,940-nm) laser for fractional ablative photothermolysis in the treatment of photodamaged facial skin: a pilot study.
Lapidoth M; Yagima Odo ME; Odo LM
Dermatol Surg; 2008 Aug; 34(8):1048-53. PubMed ID: 18462427
[TBL] [Abstract][Full Text] [Related]
73. Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis.
El-Tatawy RA; Aliweh HA; Hegab DS; Talaat RAZ; Shams Eldeen MA
Lasers Med Sci; 2019 Dec; 34(9):1873-1880. PubMed ID: 31025207
[TBL] [Abstract][Full Text] [Related]
74. Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: A split-face study.
Mekawy KMM; Sadek A; Seddeik Abdel-Hameed AK
J Cosmet Dermatol; 2021 Feb; 20(2):460-465. PubMed ID: 32562337
[TBL] [Abstract][Full Text] [Related]
75. Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman's formula in subjects with epidermal melasma: A randomized, double-blind clinical trial study.
Karrabi M; David J; Sahebkar M
Skin Res Technol; 2021 Jan; 27(1):24-31. PubMed ID: 32585079
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.
Mansouri P; Farshi S; Hashemi Z; Kasraee B
Br J Dermatol; 2015 Jul; 173(1):209-17. PubMed ID: 25251767
[TBL] [Abstract][Full Text] [Related]
77. Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients.
Lee MH; Kim HJ; Ha DJ; Paik JH; Kim HY
J Korean Med Sci; 2002 Aug; 17(4):518-23. PubMed ID: 12172049
[TBL] [Abstract][Full Text] [Related]
78. Comparative study of fractional CO
Sobhi RM; Sharaoui I; El Nabarawy EA; El Nemr Esmail RS; Hegazy RA; Aref DHF
Lasers Med Sci; 2018 May; 33(4):909-916. PubMed ID: 29480422
[TBL] [Abstract][Full Text] [Related]
79. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
Cho HH; Choi M; Cho S; Lee JH
J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
[TBL] [Abstract][Full Text] [Related]
80. The efficacy in melasma treatment using a 1410 nm fractional photothermolysis laser.
Wanitphakdeedecha R; Keoprasom N; Eimpunth S; Manuskiatti W
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):293-7. PubMed ID: 23347253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
